The International Generic and Biosimilar medicines Association (IGBA) announced today the annual leadership change of its CEO Advisory Committee (AC). Vinita Gupta, CEO of Lupin, was appointed Chair and Lucas Sigman, CEO of Insud Pharma, Vice-Chair.

Geneva, November 13, 2023 – In the week ahead, IGBA will renew its commitment to raise awareness of the powerful and lifechanging impact of biosimilar medicines which contribute to delivering better health outcomes and biologics access equity for more patients. The fourth Global Biosimilars Week (GBW) will run from 13^th to 17^th November, 2023 on social media, supported by a rich resource dedicated website globalbiosimilarsweek.org.

On October 27, 2023, the International Generics and Biosimilars Medicines Association (IGBA), including members of IGBA’s CEO Advisory Committee, met with World Health Organization (WHO) Director-General Dr. Tedros Adhanom Ghebreyesus in Geneva. During the full-day meeting, IGBA company and member association representatives, together with WHO technical experts, discussed steps both organizations can take together to expand global access to generic and biosimilar medicines.